NCL Method GTA-2
Hep G2 Hepatocarcinoma Cytotoxicity Assay
Listed in Datasets | publication by group NCL Protocols
Version 2.0b - published on 09 Jul 2020 doi:10.17917/96Z2-NZ61 - cite this
Licensed under these terms
This protocol describes the cytotoxicity testing of nanoparticle formulations in human hepatocarcinoma cells (Hep G2), as part of the in vitro NCL preclinical characterization cascade. The protocol utilizes two methods for estimation of cytotoxicity, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction and lactate dehydrogenase (LDH) release.
- NCL_Method_GTA-2.pdf(PDF | 684 KB)
Cite this work
Researchers should cite this work as follows:
- Stephan Stern, Pavan Adiseshaiah, Timothy Potter (2020). NCL Method GTA-2. (Version 2.0b). NCI Hub. doi:10.17917/96Z2-NZ61
This publication belongs to the NCL Protocols group.
When watching a publication, you will be notified when a new version is released.